Brazilian pharmaceutical manufacturer with national distribution and R&D focus
Myralis is a mid-size pharma manufacturer operating two industrial facilities in São Paulo state and a distribution hub in Minas Gerais, producing 141 million units monthly across solids, semi-solids, liquids, and injectables. The hiring profile—manufacturing and R&D roles dominate, with junior hires outpacing senior—indicates active capacity expansion rather than leadership restructuring. Pain points cluster around inventory management, QC cost reduction, and compliance governance, suggesting operational maturity pressure rather than product-market fit risk.
Notable leadership hires: Production Lead, Medical Director
Myralis manufactures pharmaceutical products and delivers them across 1,000+ Brazilian cities via major pharmacy chains. The company has two manufacturing plants (Valinhos and Aguaí) and operates a regional distribution center. Monthly output of 141 million units undergoes 100% Anvisa certification and BPF compliance. The field sales force reaches approximately 60,000 physicians monthly. Active projects span forced degradation studies, process validation, new product registration (including phytopharmaceuticals), and pilot batches for regulatory filing. The company develops both proprietary brands and contract manufacturing for downstream partners.
Myralis produces 141 million units monthly across solids, semi-solids, liquids, and injectables from two manufacturing plants in São Paulo state, with 100% Anvisa and BPF certification.
Myralis uses SAP and TOTVS for enterprise systems, Power BI and Tableau for analytics, Salesforce for CRM, PostgreSQL and MySQL for databases, and specialized tools: HPLC and ICP-MS for pharmaceutical analysis, Jenkins and GitHub Actions for deployment automation.
Other companies in the same industry, closest in size